nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—migraine—Prednisone—prostate cancer	0.286	1	CpDpCtD
Almotriptan—CYP2E1—prostate cancer	0.0854	0.382	CbGaD
Almotriptan—CYP2C19—prostate cancer	0.0845	0.378	CbGaD
Almotriptan—CYP3A4—prostate cancer	0.0538	0.24	CbGaD
Almotriptan—CYP2C8—Nilutamide—prostate cancer	0.0199	0.0672	CbGbCtD
Almotriptan—CYP2C19—Nilutamide—prostate cancer	0.0167	0.0564	CbGbCtD
Almotriptan—CYP2C19—Bicalutamide—prostate cancer	0.0167	0.0564	CbGbCtD
Almotriptan—CYP2C8—Abiraterone—prostate cancer	0.0165	0.0557	CbGbCtD
Almotriptan—CYP2E1—Estrone—prostate cancer	0.0159	0.0539	CbGbCtD
Almotriptan—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0153	0.0519	CbGbCtD
Almotriptan—CYP2C19—Flutamide—prostate cancer	0.0138	0.0467	CbGbCtD
Almotriptan—CYP1A2—Flutamide—prostate cancer	0.0127	0.0431	CbGbCtD
Almotriptan—CYP2D6—Bicalutamide—prostate cancer	0.0127	0.0428	CbGbCtD
Almotriptan—CYP2C8—Cabazitaxel—prostate cancer	0.0122	0.0412	CbGbCtD
Almotriptan—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0106	0.0359	CbGbCtD
Almotriptan—CYP2D6—Abiraterone—prostate cancer	0.0105	0.0355	CbGbCtD
Almotriptan—CYP2E1—Mitoxantrone—prostate cancer	0.00947	0.032	CbGbCtD
Almotriptan—CYP1A2—Estrone—prostate cancer	0.00921	0.0312	CbGbCtD
Almotriptan—CYP3A4—Bicalutamide—prostate cancer	0.00805	0.0272	CbGbCtD
Almotriptan—CYP3A4—Estramustine—prostate cancer	0.00749	0.0253	CbGbCtD
Almotriptan—CYP2C8—Estradiol—prostate cancer	0.00683	0.0231	CbGbCtD
Almotriptan—CYP3A4—Abiraterone—prostate cancer	0.00667	0.0226	CbGbCtD
Almotriptan—CYP3A4—Flutamide—prostate cancer	0.00667	0.0226	CbGbCtD
Almotriptan—CYP1A2—Conjugated Estrogens—prostate cancer	0.00602	0.0204	CbGbCtD
Almotriptan—CYP2E1—Etoposide—prostate cancer	0.00597	0.0202	CbGbCtD
Almotriptan—CYP2C19—Estradiol—prostate cancer	0.00573	0.0194	CbGbCtD
Almotriptan—CYP1A2—Estradiol—prostate cancer	0.00529	0.0179	CbGbCtD
Almotriptan—CYP3A4—Cabazitaxel—prostate cancer	0.00494	0.0167	CbGbCtD
Almotriptan—CYP2C19—Prednisone—prostate cancer	0.00493	0.0167	CbGbCtD
Almotriptan—CYP3A4—Estrone—prostate cancer	0.00483	0.0163	CbGbCtD
Almotriptan—CYP2C8—Etoposide—prostate cancer	0.00446	0.0151	CbGbCtD
Almotriptan—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0043	0.0145	CbGbCtD
Almotriptan—FMO3—urine—prostate cancer	0.00371	0.212	CbGeAlD
Almotriptan—CYP1A2—Etoposide—prostate cancer	0.00345	0.0117	CbGbCtD
Almotriptan—CYP3A4—Conjugated Estrogens—prostate cancer	0.00316	0.0107	CbGbCtD
Almotriptan—CYP3A4—Mitoxantrone—prostate cancer	0.00287	0.00971	CbGbCtD
Almotriptan—CYP3A4—Estradiol—prostate cancer	0.00277	0.00937	CbGbCtD
Almotriptan—CYP3A4—Prednisone—prostate cancer	0.00238	0.00806	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—prostate cancer	0.00194	0.00657	CbGbCtD
Almotriptan—CYP3A4—Etoposide—prostate cancer	0.00181	0.00612	CbGbCtD
Almotriptan—CYP3A4—Docetaxel—prostate cancer	0.00166	0.0056	CbGbCtD
Almotriptan—CYP2C19—urine—prostate cancer	0.00164	0.0935	CbGeAlD
Almotriptan—CYP1A2—urine—prostate cancer	0.00134	0.0764	CbGeAlD
Almotriptan—FMO3—prostate gland—prostate cancer	0.00133	0.0759	CbGeAlD
Almotriptan—CYP3A4—Doxorubicin—prostate cancer	0.00123	0.00417	CbGbCtD
Almotriptan—CYP2E1—urine—prostate cancer	0.00121	0.0687	CbGeAlD
Almotriptan—CYP3A4—urine—prostate cancer	0.00097	0.0553	CbGeAlD
Almotriptan—CYP2D6—urine—prostate cancer	0.000954	0.0544	CbGeAlD
Almotriptan—Melatonin—CALR—prostate cancer	0.000912	0.421	CrCbGaD
Almotriptan—FMO3—testis—prostate cancer	0.000587	0.0335	CbGeAlD
Almotriptan—MAOA—prostate gland—prostate cancer	0.000576	0.0329	CbGeAlD
Almotriptan—MAOA—seminal vesicle—prostate cancer	0.000488	0.0278	CbGeAlD
Almotriptan—CYP2E1—prostate gland—prostate cancer	0.000433	0.0247	CbGeAlD
Almotriptan—FMO3—lymph node—prostate cancer	0.000426	0.0243	CbGeAlD
Almotriptan—MAOA—renal system—prostate cancer	0.000393	0.0224	CbGeAlD
Almotriptan—MAOA—urethra—prostate cancer	0.000386	0.022	CbGeAlD
Almotriptan—CYP2E1—seminal vesicle—prostate cancer	0.000366	0.0209	CbGeAlD
Almotriptan—CYP2C8—renal system—prostate cancer	0.00035	0.02	CbGeAlD
Almotriptan—CYP1A2—renal system—prostate cancer	0.000328	0.0187	CbGeAlD
Almotriptan—CYP2E1—renal system—prostate cancer	0.000295	0.0168	CbGeAlD
Almotriptan—CYP2E1—urethra—prostate cancer	0.00029	0.0165	CbGeAlD
Almotriptan—MAOA—testis—prostate cancer	0.000254	0.0145	CbGeAlD
Almotriptan—CYP3A4—renal system—prostate cancer	0.000237	0.0135	CbGeAlD
Almotriptan—CYP2D6—renal system—prostate cancer	0.000234	0.0133	CbGeAlD
Almotriptan—CYP2C8—testis—prostate cancer	0.000226	0.0129	CbGeAlD
Almotriptan—Melatonin—CYP1B1—prostate cancer	0.000199	0.0918	CrCbGaD
Almotriptan—CYP2E1—testis—prostate cancer	0.000191	0.0109	CbGeAlD
Almotriptan—MAOA—lymph node—prostate cancer	0.000184	0.0105	CbGeAlD
Almotriptan—Melatonin—MPO—prostate cancer	0.000179	0.0827	CrCbGaD
Almotriptan—Eletriptan—CYP2A6—prostate cancer	0.000177	0.0817	CrCbGaD
Almotriptan—CYP2D6—testis—prostate cancer	0.000151	0.0086	CbGeAlD
Almotriptan—Melatonin—CYP19A1—prostate cancer	0.000146	0.0674	CrCbGaD
Almotriptan—Melatonin—ESR1—prostate cancer	0.000134	0.062	CrCbGaD
Almotriptan—Eletriptan—CYP2C19—prostate cancer	0.000124	0.0574	CrCbGaD
Almotriptan—Melatonin—CYP2C19—prostate cancer	0.000108	0.0498	CrCbGaD
Almotriptan—Melatonin—CYP1A1—prostate cancer	0.000107	0.0496	CrCbGaD
Almotriptan—Eletriptan—CYP3A4—prostate cancer	7.91e-05	0.0365	CrCbGaD
Almotriptan—Sinusitis—Epirubicin—prostate cancer	3.61e-05	0.000364	CcSEcCtD
Almotriptan—Feeling abnormal—Etoposide—prostate cancer	3.61e-05	0.000364	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—prostate cancer	3.6e-05	0.000364	CcSEcCtD
Almotriptan—Diarrhoea—Mitoxantrone—prostate cancer	3.6e-05	0.000363	CcSEcCtD
Almotriptan—Dry mouth—Capecitabine—prostate cancer	3.6e-05	0.000363	CcSEcCtD
Almotriptan—Vomiting—Estradiol—prostate cancer	3.59e-05	0.000363	CcSEcCtD
Almotriptan—Gastrointestinal pain—Etoposide—prostate cancer	3.58e-05	0.000361	CcSEcCtD
Almotriptan—Shock—Docetaxel—prostate cancer	3.58e-05	0.000361	CcSEcCtD
Almotriptan—Nervous system disorder—Docetaxel—prostate cancer	3.57e-05	0.00036	CcSEcCtD
Almotriptan—Ill-defined disorder—Prednisone—prostate cancer	3.57e-05	0.00036	CcSEcCtD
Almotriptan—Rash—Estradiol—prostate cancer	3.56e-05	0.00036	CcSEcCtD
Almotriptan—Dermatitis—Estradiol—prostate cancer	3.56e-05	0.000359	CcSEcCtD
Almotriptan—Confusional state—Capecitabine—prostate cancer	3.55e-05	0.000359	CcSEcCtD
Almotriptan—Tachycardia—Docetaxel—prostate cancer	3.55e-05	0.000358	CcSEcCtD
Almotriptan—Headache—Estradiol—prostate cancer	3.54e-05	0.000357	CcSEcCtD
Almotriptan—Skin disorder—Docetaxel—prostate cancer	3.54e-05	0.000357	CcSEcCtD
Almotriptan—Agitation—Prednisone—prostate cancer	3.54e-05	0.000357	CcSEcCtD
Almotriptan—Angioedema—Prednisone—prostate cancer	3.52e-05	0.000355	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—prostate cancer	3.49e-05	0.000352	CcSEcCtD
Almotriptan—Malaise—Prednisone—prostate cancer	3.47e-05	0.00035	CcSEcCtD
Almotriptan—Shock—Capecitabine—prostate cancer	3.47e-05	0.00035	CcSEcCtD
Almotriptan—Rhinitis—Epirubicin—prostate cancer	3.47e-05	0.00035	CcSEcCtD
Almotriptan—Body temperature increased—Etoposide—prostate cancer	3.46e-05	0.000349	CcSEcCtD
Almotriptan—Abdominal pain—Etoposide—prostate cancer	3.46e-05	0.000349	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—prostate cancer	3.46e-05	0.000349	CcSEcCtD
Almotriptan—Nervous system disorder—Capecitabine—prostate cancer	3.46e-05	0.000349	CcSEcCtD
Almotriptan—Vertigo—Prednisone—prostate cancer	3.46e-05	0.000349	CcSEcCtD
Almotriptan—Syncope—Prednisone—prostate cancer	3.45e-05	0.000348	CcSEcCtD
Almotriptan—Tachycardia—Capecitabine—prostate cancer	3.44e-05	0.000347	CcSEcCtD
Almotriptan—Hypoaesthesia—Epirubicin—prostate cancer	3.44e-05	0.000347	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—prostate cancer	3.43e-05	0.000346	CcSEcCtD
Almotriptan—Skin disorder—Capecitabine—prostate cancer	3.42e-05	0.000345	CcSEcCtD
Almotriptan—Hyperhidrosis—Capecitabine—prostate cancer	3.41e-05	0.000344	CcSEcCtD
Almotriptan—Loss of consciousness—Prednisone—prostate cancer	3.38e-05	0.000341	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—prostate cancer	3.36e-05	0.000339	CcSEcCtD
Almotriptan—Nausea—Estradiol—prostate cancer	3.36e-05	0.000339	CcSEcCtD
Almotriptan—Vomiting—Mitoxantrone—prostate cancer	3.35e-05	0.000338	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—prostate cancer	3.34e-05	0.000337	CcSEcCtD
Almotriptan—Convulsion—Prednisone—prostate cancer	3.33e-05	0.000336	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—prostate cancer	3.33e-05	0.000336	CcSEcCtD
Almotriptan—Hypertension—Prednisone—prostate cancer	3.32e-05	0.000335	CcSEcCtD
Almotriptan—Rash—Mitoxantrone—prostate cancer	3.32e-05	0.000335	CcSEcCtD
Almotriptan—Dermatitis—Mitoxantrone—prostate cancer	3.32e-05	0.000335	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.32e-05	0.000335	CcSEcCtD
Almotriptan—Headache—Mitoxantrone—prostate cancer	3.3e-05	0.000333	CcSEcCtD
Almotriptan—Insomnia—Docetaxel—prostate cancer	3.29e-05	0.000332	CcSEcCtD
Almotriptan—Arthralgia—Prednisone—prostate cancer	3.28e-05	0.00033	CcSEcCtD
Almotriptan—Myalgia—Prednisone—prostate cancer	3.28e-05	0.00033	CcSEcCtD
Almotriptan—Paraesthesia—Docetaxel—prostate cancer	3.27e-05	0.00033	CcSEcCtD
Almotriptan—Anxiety—Prednisone—prostate cancer	3.26e-05	0.000329	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.25e-05	0.000328	CcSEcCtD
Almotriptan—Dyspnoea—Docetaxel—prostate cancer	3.25e-05	0.000327	CcSEcCtD
Almotriptan—Somnolence—Docetaxel—prostate cancer	3.24e-05	0.000326	CcSEcCtD
Almotriptan—Discomfort—Prednisone—prostate cancer	3.24e-05	0.000326	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—prostate cancer	3.23e-05	0.000326	CcSEcCtD
Almotriptan—Hypersensitivity—Etoposide—prostate cancer	3.23e-05	0.000326	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—prostate cancer	3.22e-05	0.000325	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.21e-05	0.000324	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—prostate cancer	3.21e-05	0.000324	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—prostate cancer	3.21e-05	0.000323	CcSEcCtD
Almotriptan—Dyspepsia—Docetaxel—prostate cancer	3.2e-05	0.000323	CcSEcCtD
Almotriptan—Insomnia—Capecitabine—prostate cancer	3.19e-05	0.000322	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—prostate cancer	3.18e-05	0.000321	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—prostate cancer	3.17e-05	0.00032	CcSEcCtD
Almotriptan—Paraesthesia—Capecitabine—prostate cancer	3.17e-05	0.000319	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Docetaxel—prostate cancer	3.14e-05	0.000317	CcSEcCtD
Almotriptan—Asthenia—Etoposide—prostate cancer	3.14e-05	0.000317	CcSEcCtD
Almotriptan—Dyspnoea—Capecitabine—prostate cancer	3.14e-05	0.000317	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisone—prostate cancer	3.14e-05	0.000317	CcSEcCtD
Almotriptan—Fatigue—Docetaxel—prostate cancer	3.14e-05	0.000317	CcSEcCtD
Almotriptan—Nausea—Mitoxantrone—prostate cancer	3.13e-05	0.000316	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—prostate cancer	3.12e-05	0.000315	CcSEcCtD
Almotriptan—Pain—Docetaxel—prostate cancer	3.11e-05	0.000314	CcSEcCtD
Almotriptan—Dyspepsia—Capecitabine—prostate cancer	3.1e-05	0.000313	CcSEcCtD
Almotriptan—Chills—Epirubicin—prostate cancer	3.1e-05	0.000313	CcSEcCtD
Almotriptan—Pruritus—Etoposide—prostate cancer	3.1e-05	0.000313	CcSEcCtD
Almotriptan—Shock—Prednisone—prostate cancer	3.09e-05	0.000312	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—prostate cancer	3.08e-05	0.000311	CcSEcCtD
Almotriptan—Nervous system disorder—Prednisone—prostate cancer	3.08e-05	0.000311	CcSEcCtD
Almotriptan—Tachycardia—Prednisone—prostate cancer	3.06e-05	0.000309	CcSEcCtD
Almotriptan—Skin disorder—Prednisone—prostate cancer	3.05e-05	0.000308	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Capecitabine—prostate cancer	3.04e-05	0.000307	CcSEcCtD
Almotriptan—Fatigue—Capecitabine—prostate cancer	3.04e-05	0.000307	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisone—prostate cancer	3.04e-05	0.000306	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—prostate cancer	3.03e-05	0.000305	CcSEcCtD
Almotriptan—Pain—Capecitabine—prostate cancer	3.01e-05	0.000304	CcSEcCtD
Almotriptan—Erythema—Epirubicin—prostate cancer	3.01e-05	0.000304	CcSEcCtD
Almotriptan—Feeling abnormal—Docetaxel—prostate cancer	3e-05	0.000303	CcSEcCtD
Almotriptan—Diarrhoea—Etoposide—prostate cancer	3e-05	0.000302	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—prostate cancer	2.99e-05	0.000301	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—prostate cancer	2.98e-05	0.000301	CcSEcCtD
Almotriptan—Gastrointestinal pain—Docetaxel—prostate cancer	2.98e-05	0.0003	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—prostate cancer	2.97e-05	0.000299	CcSEcCtD
Almotriptan—Tension—Epirubicin—prostate cancer	2.95e-05	0.000298	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—prostate cancer	2.95e-05	0.000297	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—prostate cancer	2.92e-05	0.000295	CcSEcCtD
Almotriptan—Back pain—Epirubicin—prostate cancer	2.91e-05	0.000294	CcSEcCtD
Almotriptan—Feeling abnormal—Capecitabine—prostate cancer	2.9e-05	0.000293	CcSEcCtD
Almotriptan—Dizziness—Etoposide—prostate cancer	2.9e-05	0.000292	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—prostate cancer	2.89e-05	0.000291	CcSEcCtD
Almotriptan—Gastrointestinal pain—Capecitabine—prostate cancer	2.88e-05	0.000291	CcSEcCtD
Almotriptan—Abdominal pain—Docetaxel—prostate cancer	2.88e-05	0.00029	CcSEcCtD
Almotriptan—Body temperature increased—Docetaxel—prostate cancer	2.88e-05	0.00029	CcSEcCtD
Almotriptan—Chills—Doxorubicin—prostate cancer	2.87e-05	0.000289	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Prednisone—prostate cancer	2.86e-05	0.000289	CcSEcCtD
Almotriptan—Insomnia—Prednisone—prostate cancer	2.84e-05	0.000286	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—prostate cancer	2.84e-05	0.000286	CcSEcCtD
Almotriptan—Paraesthesia—Prednisone—prostate cancer	2.82e-05	0.000284	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—prostate cancer	2.8e-05	0.000283	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—prostate cancer	2.79e-05	0.000282	CcSEcCtD
Almotriptan—Abdominal pain—Capecitabine—prostate cancer	2.79e-05	0.000281	CcSEcCtD
Almotriptan—Body temperature increased—Capecitabine—prostate cancer	2.79e-05	0.000281	CcSEcCtD
Almotriptan—Vomiting—Etoposide—prostate cancer	2.79e-05	0.000281	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—prostate cancer	2.78e-05	0.000281	CcSEcCtD
Almotriptan—Agitation—Epirubicin—prostate cancer	2.77e-05	0.000279	CcSEcCtD
Almotriptan—Dyspepsia—Prednisone—prostate cancer	2.76e-05	0.000279	CcSEcCtD
Almotriptan—Rash—Etoposide—prostate cancer	2.76e-05	0.000279	CcSEcCtD
Almotriptan—Dermatitis—Etoposide—prostate cancer	2.76e-05	0.000278	CcSEcCtD
Almotriptan—Headache—Etoposide—prostate cancer	2.74e-05	0.000277	CcSEcCtD
Almotriptan—Tension—Doxorubicin—prostate cancer	2.73e-05	0.000276	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—prostate cancer	2.73e-05	0.000275	CcSEcCtD
Almotriptan—Malaise—Epirubicin—prostate cancer	2.71e-05	0.000274	CcSEcCtD
Almotriptan—Fatigue—Prednisone—prostate cancer	2.71e-05	0.000273	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—prostate cancer	2.7e-05	0.000273	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—prostate cancer	2.7e-05	0.000273	CcSEcCtD
Almotriptan—Syncope—Epirubicin—prostate cancer	2.7e-05	0.000272	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—prostate cancer	2.69e-05	0.000272	CcSEcCtD
Almotriptan—Hypersensitivity—Docetaxel—prostate cancer	2.68e-05	0.000271	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—prostate cancer	2.66e-05	0.000268	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—prostate cancer	2.64e-05	0.000267	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—prostate cancer	2.62e-05	0.000265	CcSEcCtD
Almotriptan—Asthenia—Docetaxel—prostate cancer	2.61e-05	0.000263	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—prostate cancer	2.61e-05	0.000263	CcSEcCtD
Almotriptan—Nausea—Etoposide—prostate cancer	2.6e-05	0.000262	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—prostate cancer	2.6e-05	0.000262	CcSEcCtD
Almotriptan—Hypersensitivity—Capecitabine—prostate cancer	2.6e-05	0.000262	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisone—prostate cancer	2.59e-05	0.000261	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—prostate cancer	2.58e-05	0.000261	CcSEcCtD
Almotriptan—Pruritus—Docetaxel—prostate cancer	2.58e-05	0.00026	CcSEcCtD
Almotriptan—Gastrointestinal pain—Prednisone—prostate cancer	2.57e-05	0.000259	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—prostate cancer	2.56e-05	0.000258	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—prostate cancer	2.56e-05	0.000258	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—prostate cancer	2.56e-05	0.000258	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—prostate cancer	2.56e-05	0.000258	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—prostate cancer	2.55e-05	0.000258	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.54e-05	0.000257	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—prostate cancer	2.53e-05	0.000255	CcSEcCtD
Almotriptan—Asthenia—Capecitabine—prostate cancer	2.53e-05	0.000255	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—prostate cancer	2.51e-05	0.000253	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—prostate cancer	2.51e-05	0.000253	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—prostate cancer	2.5e-05	0.000252	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—prostate cancer	2.5e-05	0.000252	CcSEcCtD
Almotriptan—Pruritus—Capecitabine—prostate cancer	2.49e-05	0.000252	CcSEcCtD
Almotriptan—Diarrhoea—Docetaxel—prostate cancer	2.49e-05	0.000251	CcSEcCtD
Almotriptan—Abdominal pain—Prednisone—prostate cancer	2.48e-05	0.00025	CcSEcCtD
Almotriptan—Body temperature increased—Prednisone—prostate cancer	2.48e-05	0.00025	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—prostate cancer	2.48e-05	0.00025	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—prostate cancer	2.46e-05	0.000248	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—prostate cancer	2.46e-05	0.000248	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—prostate cancer	2.45e-05	0.000247	CcSEcCtD
Almotriptan—Shock—Epirubicin—prostate cancer	2.42e-05	0.000244	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—prostate cancer	2.41e-05	0.000243	CcSEcCtD
Almotriptan—Diarrhoea—Capecitabine—prostate cancer	2.41e-05	0.000243	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—prostate cancer	2.41e-05	0.000243	CcSEcCtD
Almotriptan—Dizziness—Docetaxel—prostate cancer	2.41e-05	0.000243	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—prostate cancer	2.4e-05	0.000242	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—prostate cancer	2.4e-05	0.000242	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—prostate cancer	2.39e-05	0.000241	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—prostate cancer	2.37e-05	0.000239	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—prostate cancer	2.37e-05	0.000239	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—prostate cancer	2.37e-05	0.000239	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—prostate cancer	2.37e-05	0.000239	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—prostate cancer	2.36e-05	0.000238	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.35e-05	0.000237	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—prostate cancer	2.34e-05	0.000236	CcSEcCtD
Almotriptan—Dizziness—Capecitabine—prostate cancer	2.33e-05	0.000235	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—prostate cancer	2.32e-05	0.000234	CcSEcCtD
Almotriptan—Vomiting—Docetaxel—prostate cancer	2.31e-05	0.000234	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisone—prostate cancer	2.31e-05	0.000233	CcSEcCtD
Almotriptan—Rash—Docetaxel—prostate cancer	2.3e-05	0.000232	CcSEcCtD
Almotriptan—Dermatitis—Docetaxel—prostate cancer	2.29e-05	0.000231	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—prostate cancer	2.29e-05	0.000231	CcSEcCtD
Almotriptan—Headache—Docetaxel—prostate cancer	2.28e-05	0.00023	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—prostate cancer	2.27e-05	0.000229	CcSEcCtD
Almotriptan—Asthenia—Prednisone—prostate cancer	2.25e-05	0.000227	CcSEcCtD
Almotriptan—Vomiting—Capecitabine—prostate cancer	2.24e-05	0.000226	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.24e-05	0.000226	CcSEcCtD
Almotriptan—Shock—Doxorubicin—prostate cancer	2.24e-05	0.000225	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—prostate cancer	2.23e-05	0.000225	CcSEcCtD
Almotriptan—Rash—Capecitabine—prostate cancer	2.22e-05	0.000224	CcSEcCtD
Almotriptan—Pruritus—Prednisone—prostate cancer	2.22e-05	0.000224	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—prostate cancer	2.22e-05	0.000224	CcSEcCtD
Almotriptan—Dermatitis—Capecitabine—prostate cancer	2.22e-05	0.000224	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—prostate cancer	2.22e-05	0.000224	CcSEcCtD
Almotriptan—Headache—Capecitabine—prostate cancer	2.21e-05	0.000223	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—prostate cancer	2.21e-05	0.000223	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—prostate cancer	2.21e-05	0.000222	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—prostate cancer	2.2e-05	0.000222	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—prostate cancer	2.19e-05	0.000221	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—prostate cancer	2.18e-05	0.00022	CcSEcCtD
Almotriptan—Nausea—Docetaxel—prostate cancer	2.16e-05	0.000218	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—prostate cancer	2.16e-05	0.000218	CcSEcCtD
Almotriptan—Diarrhoea—Prednisone—prostate cancer	2.15e-05	0.000217	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—prostate cancer	2.12e-05	0.000214	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—prostate cancer	2.12e-05	0.000214	CcSEcCtD
Almotriptan—Pain—Epirubicin—prostate cancer	2.1e-05	0.000212	CcSEcCtD
Almotriptan—Nausea—Capecitabine—prostate cancer	2.09e-05	0.000211	CcSEcCtD
Almotriptan—Dizziness—Prednisone—prostate cancer	2.08e-05	0.000209	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.07e-05	0.000209	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—prostate cancer	2.06e-05	0.000207	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—prostate cancer	2.04e-05	0.000206	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—prostate cancer	2.03e-05	0.000204	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—prostate cancer	2.02e-05	0.000204	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—prostate cancer	2.02e-05	0.000204	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—prostate cancer	2.01e-05	0.000203	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—prostate cancer	2e-05	0.000202	CcSEcCtD
Almotriptan—Vomiting—Prednisone—prostate cancer	2e-05	0.000201	CcSEcCtD
Almotriptan—Rash—Prednisone—prostate cancer	1.98e-05	0.0002	CcSEcCtD
Almotriptan—Dermatitis—Prednisone—prostate cancer	1.98e-05	0.0002	CcSEcCtD
Almotriptan—Headache—Prednisone—prostate cancer	1.97e-05	0.000198	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.96e-05	0.000198	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—prostate cancer	1.96e-05	0.000198	CcSEcCtD
Almotriptan—Pain—Doxorubicin—prostate cancer	1.94e-05	0.000196	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—prostate cancer	1.94e-05	0.000196	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—prostate cancer	1.94e-05	0.000196	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—prostate cancer	1.87e-05	0.000189	CcSEcCtD
Almotriptan—Nausea—Prednisone—prostate cancer	1.87e-05	0.000188	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—prostate cancer	1.86e-05	0.000187	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—prostate cancer	1.81e-05	0.000183	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—prostate cancer	1.8e-05	0.000181	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—prostate cancer	1.8e-05	0.000181	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—prostate cancer	1.76e-05	0.000178	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—prostate cancer	1.74e-05	0.000175	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—prostate cancer	1.68e-05	0.000169	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—prostate cancer	1.67e-05	0.000169	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—prostate cancer	1.63e-05	0.000164	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—prostate cancer	1.62e-05	0.000164	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—prostate cancer	1.61e-05	0.000162	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—prostate cancer	1.56e-05	0.000157	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—prostate cancer	1.55e-05	0.000157	CcSEcCtD
Almotriptan—Rash—Epirubicin—prostate cancer	1.55e-05	0.000156	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—prostate cancer	1.55e-05	0.000156	CcSEcCtD
Almotriptan—Headache—Epirubicin—prostate cancer	1.54e-05	0.000155	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—prostate cancer	1.5e-05	0.000152	CcSEcCtD
Almotriptan—Nausea—Epirubicin—prostate cancer	1.46e-05	0.000147	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—prostate cancer	1.44e-05	0.000146	CcSEcCtD
Almotriptan—Rash—Doxorubicin—prostate cancer	1.43e-05	0.000145	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—prostate cancer	1.43e-05	0.000144	CcSEcCtD
Almotriptan—Headache—Doxorubicin—prostate cancer	1.42e-05	0.000144	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—prostate cancer	1.35e-05	0.000136	CcSEcCtD
Almotriptan—HTR1D—Signaling Pathways—JAK2—prostate cancer	1.82e-06	2.39e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.82e-06	2.39e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CB—prostate cancer	1.82e-06	2.39e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NQO1—prostate cancer	1.81e-06	2.38e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ITPR1—prostate cancer	1.81e-06	2.38e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NCOA1—prostate cancer	1.8e-06	2.37e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—prostate cancer	1.8e-06	2.36e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TH—prostate cancer	1.79e-06	2.35e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—prostate cancer	1.79e-06	2.35e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—JAK2—prostate cancer	1.79e-06	2.34e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.78e-06	2.34e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MDM2—prostate cancer	1.78e-06	2.34e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1C3—prostate cancer	1.78e-06	2.33e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.78e-06	2.33e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.77e-06	2.32e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PRKACB—prostate cancer	1.77e-06	2.32e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLCB2—prostate cancer	1.76e-06	2.32e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.76e-06	2.32e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LRP2—prostate cancer	1.76e-06	2.32e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB2—prostate cancer	1.75e-06	2.3e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP17A1—prostate cancer	1.75e-06	2.3e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—prostate cancer	1.75e-06	2.3e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MDM2—prostate cancer	1.74e-06	2.29e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.74e-06	2.28e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—prostate cancer	1.73e-06	2.27e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CB—prostate cancer	1.73e-06	2.27e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—P4HB—prostate cancer	1.73e-06	2.27e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.73e-06	2.27e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB2—prostate cancer	1.72e-06	2.26e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—RXRA—prostate cancer	1.72e-06	2.25e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TYMS—prostate cancer	1.71e-06	2.25e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARA—prostate cancer	1.7e-06	2.23e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CB—prostate cancer	1.7e-06	2.23e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—prostate cancer	1.69e-06	2.22e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GGT1—prostate cancer	1.68e-06	2.21e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.68e-06	2.21e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.67e-06	2.19e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NCOA2—prostate cancer	1.67e-06	2.19e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL8—prostate cancer	1.66e-06	2.18e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—LPL—prostate cancer	1.66e-06	2.18e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NCOA1—prostate cancer	1.66e-06	2.18e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—COMT—prostate cancer	1.65e-06	2.17e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTP1—prostate cancer	1.65e-06	2.16e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.64e-06	2.15e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.64e-06	2.15e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL8—prostate cancer	1.63e-06	2.14e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—prostate cancer	1.63e-06	2.13e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ITPR1—prostate cancer	1.62e-06	2.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MED12—prostate cancer	1.61e-06	2.12e-05	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—prostate cancer	1.61e-06	2.11e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.61e-06	2.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GNG5—prostate cancer	1.6e-06	2.1e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAV1—prostate cancer	1.6e-06	2.1e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—prostate cancer	1.59e-06	2.09e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ERCC2—prostate cancer	1.59e-06	2.09e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.59e-06	2.09e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.59e-06	2.09e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—prostate cancer	1.59e-06	2.09e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—prostate cancer	1.59e-06	2.09e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—prostate cancer	1.58e-06	2.08e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—RXRA—prostate cancer	1.58e-06	2.07e-05	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—prostate cancer	1.57e-06	2.07e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—prostate cancer	1.57e-06	2.06e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—prostate cancer	1.56e-06	2.05e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—prostate cancer	1.56e-06	2.04e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.55e-06	2.04e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—prostate cancer	1.55e-06	2.04e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—prostate cancer	1.55e-06	2.03e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOA3—prostate cancer	1.54e-06	2.02e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NQO1—prostate cancer	1.54e-06	2.02e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—prostate cancer	1.54e-06	2.02e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TYMS—prostate cancer	1.53e-06	2.01e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—COMT—prostate cancer	1.52e-06	2e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—prostate cancer	1.52e-06	1.99e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TH—prostate cancer	1.51e-06	1.99e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTP1—prostate cancer	1.51e-06	1.99e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—prostate cancer	1.51e-06	1.98e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—prostate cancer	1.51e-06	1.98e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.5e-06	1.98e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—prostate cancer	1.5e-06	1.97e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1A—prostate cancer	1.5e-06	1.97e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.5e-06	1.97e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—EP300—prostate cancer	1.5e-06	1.97e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—prostate cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—prostate cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.49e-06	1.96e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ITPR1—prostate cancer	1.49e-06	1.95e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—LPL—prostate cancer	1.48e-06	1.95e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—prostate cancer	1.47e-06	1.93e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.47e-06	1.93e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HPGDS—prostate cancer	1.47e-06	1.93e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARA—prostate cancer	1.47e-06	1.93e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1A—prostate cancer	1.47e-06	1.93e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—prostate cancer	1.47e-06	1.92e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.46e-06	1.92e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—prostate cancer	1.46e-06	1.92e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.46e-06	1.91e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.43e-06	1.88e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—prostate cancer	1.43e-06	1.88e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ACHE—prostate cancer	1.43e-06	1.87e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—prostate cancer	1.43e-06	1.87e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GGT1—prostate cancer	1.43e-06	1.87e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EP300—prostate cancer	1.43e-06	1.87e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ERCC2—prostate cancer	1.42e-06	1.87e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.41e-06	1.85e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TYMS—prostate cancer	1.41e-06	1.85e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NCOA1—prostate cancer	1.41e-06	1.85e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EP300—prostate cancer	1.4e-06	1.83e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—prostate cancer	1.39e-06	1.83e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SRC—prostate cancer	1.39e-06	1.82e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.39e-06	1.82e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAV1—prostate cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—INS—prostate cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.37e-06	1.8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PRKACB—prostate cancer	1.37e-06	1.79e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—LPL—prostate cancer	1.36e-06	1.79e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SRC—prostate cancer	1.36e-06	1.78e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—prostate cancer	1.35e-06	1.77e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.35e-06	1.77e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CREBBP—prostate cancer	1.35e-06	1.77e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—prostate cancer	1.34e-06	1.76e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—RXRA—prostate cancer	1.34e-06	1.76e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—prostate cancer	1.34e-06	1.75e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—prostate cancer	1.32e-06	1.74e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.32e-06	1.73e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.32e-06	1.73e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARA—prostate cancer	1.31e-06	1.72e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—prostate cancer	1.31e-06	1.72e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ERCC2—prostate cancer	1.31e-06	1.72e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.3e-06	1.71e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—COMT—prostate cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOA2—prostate cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTP1—prostate cancer	1.28e-06	1.68e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.28e-06	1.68e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ITPR1—prostate cancer	1.26e-06	1.66e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.26e-06	1.65e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—prostate cancer	1.24e-06	1.63e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—prostate cancer	1.24e-06	1.63e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.24e-06	1.63e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAV1—prostate cancer	1.23e-06	1.62e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—prostate cancer	1.23e-06	1.61e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.23e-06	1.61e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—prostate cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—prostate cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—prostate cancer	1.21e-06	1.59e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—prostate cancer	1.21e-06	1.59e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARA—prostate cancer	1.21e-06	1.58e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.2e-06	1.57e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMS—prostate cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—prostate cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—INS—prostate cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NQO1—prostate cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—prostate cancer	1.18e-06	1.55e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.18e-06	1.55e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TH—prostate cancer	1.17e-06	1.53e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CREBBP—prostate cancer	1.17e-06	1.53e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LPL—prostate cancer	1.16e-06	1.52e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—prostate cancer	1.15e-06	1.51e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.14e-06	1.49e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAV1—prostate cancer	1.13e-06	1.49e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—prostate cancer	1.13e-06	1.48e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.12e-06	1.47e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.12e-06	1.47e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.11e-06	1.46e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—prostate cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ERCC2—prostate cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—prostate cancer	1.1e-06	1.45e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GGT1—prostate cancer	1.1e-06	1.45e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NCOA1—prostate cancer	1.08e-06	1.42e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.07e-06	1.4e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—INS—prostate cancer	1.06e-06	1.39e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—prostate cancer	1.06e-06	1.39e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—prostate cancer	1.04e-06	1.37e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—prostate cancer	1.04e-06	1.37e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CREBBP—prostate cancer	1.04e-06	1.37e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	1.03e-06	1.36e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.03e-06	1.36e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—RXRA—prostate cancer	1.03e-06	1.35e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARA—prostate cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—prostate cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—prostate cancer	1e-06	1.31e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—COMT—prostate cancer	9.94e-07	1.3e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTP1—prostate cancer	9.89e-07	1.3e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CD—prostate cancer	9.87e-07	1.3e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—INS—prostate cancer	9.77e-07	1.28e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ITPR1—prostate cancer	9.73e-07	1.28e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CB—prostate cancer	9.64e-07	1.27e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—prostate cancer	9.63e-07	1.26e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAV1—prostate cancer	9.6e-07	1.26e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CREBBP—prostate cancer	9.57e-07	1.26e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—prostate cancer	9.55e-07	1.25e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—prostate cancer	9.35e-07	1.23e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—prostate cancer	9.32e-07	1.22e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMS—prostate cancer	9.2e-07	1.21e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—EP300—prostate cancer	9.19e-07	1.21e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.17e-07	1.2e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—prostate cancer	9.15e-07	1.2e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—prostate cancer	9.09e-07	1.19e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CD—prostate cancer	9.08e-07	1.19e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—prostate cancer	9.05e-07	1.19e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LPL—prostate cancer	8.92e-07	1.17e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CG—prostate cancer	8.75e-07	1.15e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—prostate cancer	8.62e-07	1.13e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A1—prostate cancer	8.62e-07	1.13e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CB—prostate cancer	8.6e-07	1.13e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—prostate cancer	8.57e-07	1.13e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ERCC2—prostate cancer	8.55e-07	1.12e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—prostate cancer	8.52e-07	1.12e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—prostate cancer	8.44e-07	1.11e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—prostate cancer	8.33e-07	1.09e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—INS—prostate cancer	8.28e-07	1.09e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CREBBP—prostate cancer	8.11e-07	1.06e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—prostate cancer	8.03e-07	1.05e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—EP300—prostate cancer	7.94e-07	1.04e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CB—prostate cancer	7.91e-07	1.04e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARA—prostate cancer	7.88e-07	1.03e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—prostate cancer	7.84e-07	1.03e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CD—prostate cancer	7.69e-07	1.01e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—prostate cancer	7.43e-07	9.76e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAV1—prostate cancer	7.41e-07	9.73e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—prostate cancer	7.26e-07	9.53e-06	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—EP300—prostate cancer	7.09e-07	9.3e-06	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—prostate cancer	6.84e-07	8.97e-06	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—prostate cancer	6.8e-07	8.92e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CG—prostate cancer	6.75e-07	8.86e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CB—prostate cancer	6.7e-07	8.8e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—prostate cancer	6.64e-07	8.72e-06	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—EP300—prostate cancer	6.52e-07	8.56e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—INS—prostate cancer	6.39e-07	8.39e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CREBBP—prostate cancer	6.26e-07	8.22e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CD—prostate cancer	5.93e-07	7.79e-06	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—prostate cancer	5.87e-07	7.71e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—prostate cancer	5.79e-07	7.6e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—prostate cancer	5.6e-07	7.36e-06	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—prostate cancer	5.55e-07	7.29e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—EP300—prostate cancer	5.52e-07	7.25e-06	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.24e-07	6.88e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.17e-07	6.79e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—prostate cancer	5.13e-07	6.73e-06	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.82e-07	6.33e-06	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—prostate cancer	4.8e-07	6.3e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—prostate cancer	4.47e-07	5.87e-06	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—prostate cancer	4.28e-07	5.62e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—EP300—prostate cancer	4.26e-07	5.6e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.09e-07	5.36e-06	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—prostate cancer	3.94e-07	5.17e-06	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—prostate cancer	3.34e-07	4.38e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.15e-07	4.14e-06	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—prostate cancer	2.58e-07	3.38e-06	CbGpPWpGaD
